Wednesday, August 15, 2018
Company News: Page (1) of 1 - 12/06/17 Email this story to a friend. email article Print this page (Article printing at page facebook
Novasep Invests 17 M in "mAbulous", its Dedicated cGMP Monoclonal Antibody (mAb) Production Facility
The facility will address increasing demand for small-volume mAb CDMO services
By PR Newswire
This article is no longer available,but here are some related topics.

Page: 1


Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines